logo

For the Inventor, By the Inventor

Montreal, Canada

Tibor Bogri

This inventor holds 30 USPTO granted patents, primarily in Prostaglandin Derivatives. Top assignees: Ayerst, Mckenna & Harrison, Inc., American Home Products Corporation. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tibor Bogri. Retrieved from https://idiyas.com/inventor/tibor-bogri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 64(Granted Patents)


Location History:

  • St. Laurent, CA (1982 - 1983)
  • Montreal, CA (1976 - 1985)

Company Filing History:

goldMedal20 out of 117 
 
Ayerst, Mckenna & Harrison, Inc.
 patents
silverMedal10 out of 1,567 
 
American Home Products Corporation
 patents

Years Active: 1976-1985

Loading Chart...
Areas of Expertise:
Prostaglandin
Antihypertensive
Cyclohepta
Ketenemercaptal
Piperazinyl
Troponyl
Tropone
Dihydro
Alkyl Derivatives
Cyclopentanone
Composition
Intermediates
30 patents (USPTO):Explore Patents
1. 4542140 - Pyridinyl substituted ketenemercaptal derivatives (1985-09-17),
2. 4469695 - 2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives (1984-09-04),
3. 4469694 - 2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives (1984-09-04),
4. 4469693 - 2-(4-Substituted alkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one (1984-09-04),
5. 4382088 - 4,7-Dihydro-4,7-dioxi-1H-cyclohepta[b]pyridine derivatives (1983-05-03),
6. 4381304 - 4,9-Dihydro-4,9-dioxo-1H-cyclohepta[b]pyridine derivatives (1983-04-26),
7. 4375470 - 2(1-Piperazinyl)-cycloheptimidazole antihypertensive composition and (1983-03-01),
8. 4337265 - Cyclohepta[b]pyrrole derivatives (1982-06-29),
9. 4258188 - 2-(1-Piperazinyl)-cycloheptimidazole derivatives (1981-03-24),
10. 4183955 - Troponyl-oxamic acid derivatives for treating allergic conditions (1980-01-15),
11. 4161608 - 11 Hydroxy methyl 11-deoxyprostaglandin E.sub.1 (1979-07-17),
12. 4152457 - Tropone derivatives (1979-05-01),
13. 4152456 - Tropone derivatives (1979-05-01),
14. 4144251 - 5-Unsaturated prostanoic acid derivatives (1979-03-13),
15. 4130649 - Cyclohepta [B]pyridine-2-carboxylic acid derivatives (1978-12-19),

Title: Tibor Bogri: A Pioneer in Pharmaceutical Innovations

Introduction

Tibor Bogri, based in Montreal, Canada, is a notable inventor with an impressive portfolio of 30 patents. His work primarily focuses on developing innovative pharmaceutical derivatives aimed at addressing significant health issues.

Latest Patents

Two of Tibor Bogri's latest patents include pyridinyl substituted ketenemercaptal derivatives and 2-(1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives. The former, characterized by a heterocyclic containing mercapto radical, is designed for treating ulcers and suppressing gastric acid secretion. Meanwhile, the latter patent claims derivatives that demonstrate dopamine-receptor-stimulating activity, proving beneficial for conditions such as hyperprolactinemia, galactorrhea, amenorrhea, impotence, Parkinsonism, diabetes, acromegaly, hypertension, and other central nervous system disorders.

Career Highlights

Throughout his career, Tibor has contributed to several esteemed companies, including Ayerst and American Home Products Corporation. His work has consistently sought innovative solutions in the pharmaceutical industry, leading to advancements in therapeutic options for various ailments.

Collaborations

Tibor has collaborated with notable colleagues, including Jehan F. Bagli and Nedumparambil A. Abraham. These collaborations have fostered an environment of innovation, resulting in the successful development of impactful pharmaceutical products.

Conclusion

Tibor Bogri's dedication to innovation and his extensive contributions to pharmaceutical sciences underscore the significance of his work. With ongoing advancements and a growing list of patents, he continues to be a driving force in the development of effective treatments for a myriad of health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…